ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,381, issued on Dec. 23, was assigned to RedHill Biopharma Ltd. (Tel-Aviv, Israel).
"Serine protease inhibitor for treating coronavirus infection" was invented by Dror Ben-Asher (Tel-Aviv, Israel) and Reza Fathi (Oradell, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to WX-671, as (L)- or (D)-enantiomers, and as E- or (Z)-isomers or (E/Z)-mixtures, and as free bases or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection."
The patent ...